Twin Tree Management, LP Neurocrine Biosciences Inc Transaction History

Twin Tree Management, LP

  • $22.8 Billion
  • Q3 2025

A detailed history of Twin Tree Management, LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Twin Tree Management, LP holds 7,900 shares of NBIX stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,900
Previous 71,300 88.92%
Holding current value
$1.14 Million
Previous $8.96 Million 87.62%
% of portfolio
0.0%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$123.98 - $146.67 $596,343 - $705,482
4,810 New
4,810 $675,000
Q3 2024

Nov 12, 2024
BUY
$114.58 - $153.15 $3.22 Million - $4.3 Million
28,105 New
28,105 $3.24 Million
Q1 2024

May 09, 2024
SELL
$130.4 - $143.74 $2.32 Million - $2.55 Million
-17,764 Reduced 48.13%
19,147 $2.64 Million
Q4 2023

Feb 14, 2024
BUY
$106.07 - $132.76 $1.35 Million - $1.69 Million
12,712 Added 52.53%
36,911 $4.86 Million
Q3 2023

Nov 14, 2023
BUY
$94.02 - $117.1 $1.79 Million - $2.23 Million
19,022 Added 367.43%
24,199 $2.72 Million
Q2 2023

Aug 11, 2023
BUY
$89.53 - $104.87 $463,496 - $542,911
5,177 New
5,177 $488,000
Q3 2022

Nov 10, 2022
BUY
$92.03 - $107.81 $718,938 - $842,211
7,812 Added 167.46%
12,477 $1.33 Million
Q2 2022

Aug 11, 2022
SELL
$75.79 - $100.07 $544,323 - $718,702
-7,182 Reduced 60.62%
4,665 $455,000
Q1 2022

May 11, 2022
BUY
$72.45 - $94.81 $655,889 - $858,314
9,053 Added 324.02%
11,847 $1.11 Million
Q4 2021

Feb 10, 2022
SELL
$79.65 - $106.22 $939,870 - $1.25 Million
-11,800 Reduced 80.86%
2,794 $238,000
Q3 2021

Nov 12, 2021
SELL
$86.18 - $99.03 $765,536 - $879,683
-8,883 Reduced 37.84%
14,594 $1.4 Million
Q2 2021

Aug 12, 2021
BUY
$89.43 - $102.27 $1.55 Million - $1.77 Million
17,310 Added 280.69%
23,477 $2.29 Million
Q1 2021

May 17, 2021
BUY
$87.57 - $119.4 $385,045 - $525,001
4,397 Added 248.42%
6,167 $600,000
Q4 2020

Feb 12, 2021
SELL
$86.91 - $108.33 $511,030 - $636,980
-5,880 Reduced 76.86%
1,770 $170,000
Q3 2020

Nov 13, 2020
BUY
$96.16 - $135.15 $238,380 - $335,036
2,479 Added 47.94%
7,650 $736,000
Q2 2020

Aug 12, 2020
BUY
$85.09 - $130.36 $435,745 - $667,573
5,121 Added 10242.0%
5,171 $631,000
Q1 2020

May 13, 2020
SELL
$75.11 - $113.76 $194,459 - $294,524
-2,589 Reduced 98.11%
50 $4,000
Q4 2019

Feb 14, 2020
BUY
$86.8 - $118.57 $10,589 - $14,465
122 Added 4.85%
2,639 $284,000
Q3 2019

Nov 12, 2019
BUY
$83.82 - $101.5 $33,444 - $40,498
399 Added 18.84%
2,517 $227,000
Q1 2019

May 10, 2019
SELL
$69.31 - $91.53 $84,488 - $111,575
-1,219 Reduced 36.53%
2,118 $187,000
Q4 2018

Feb 13, 2019
BUY
$68.32 - $124.36 $227,983 - $414,989
3,337 New
3,337 $238,000

Others Institutions Holding NBIX

# of Institutions
724
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email